Congratulations to our client Chemomab Therapeutics (“Chemomab”) on completing a merger with public company Anchiano Therapeutics. The combined company now goes by Chemomab Therapeutics Ltd. and is traded on Nasdaq
Continue Reading Congratulations to GT Client Chemomab on Recent Merger
On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with
Continue Reading Greenberg Traurig Hosts Wharton Israel Conference Monday, June 6, 2016